metformin has been researched along with cimetidine in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.72) | 18.7374 |
1990's | 1 (1.72) | 18.2507 |
2000's | 17 (29.31) | 29.6817 |
2010's | 35 (60.34) | 24.3611 |
2020's | 4 (6.90) | 2.80 |
Authors | Studies |
---|---|
Artursson, P; Bergström, CA; Matsson, P; Nagahara, N; Norinder, U; Tavelin, S | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Blomgren, A; Börjesson, L; Gustavsson, L; Hendrickx, R; Jenvert, RM; Johansson, JG; Lohmann, C | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chen, EC; Chien, HC; Giacomini, KM; Huang, Y; Khuri, N; Liang, X; Sali, A; Stecula, A; Yee, SW | 1 |
Bochner, F; Keal, J; Rolan, P; Somogyi, A; Stockley, C | 1 |
Guanci, R; Lilley, LL | 1 |
Jonker, JW; Kato, Y; Kusuhara, H; Schinkel, AH; Sugiyama, Y; Wang, DS | 1 |
Sanders, TA; Taylor, D; Werneke, U | 1 |
Conlon, C; Dawson, D | 1 |
Ahmed, N; Arayne, MS; Sultana, N | 1 |
Iwatsubo, T; Kamimura, H; Noguchi, K; Umehara, KI | 2 |
Chow, MS; Tomlinson, B; Wang, ZJ; Yin, OQ | 1 |
Begg, EJ; Gardiner, SJ; Kirkpatrick, CM; Zhang, M | 1 |
Inui, K; Katsura, T; Masuda, S; Sato, T; Tanihara, Y; Yonezawa, A | 1 |
Iwatsubo, T; Kamimura, H; Noguchi, K; Umehara, KI; Usui, T | 1 |
Inui, K; Katsura, T; Masuda, S; Sato, T; Terada, T; Tsuda, M; Ueba, M | 1 |
Ekblad, U; Heikkinen, T; Laine, K; Rahi, M; Rönnemaa, T; Tertti, K | 1 |
Christopher, R; Covington, P; Davenport, M; Fleck, P; Karim, A; Li, X; Mekki, Q; Wann, E | 1 |
Boehm, KM; Gunaga, S | 1 |
Arayne, MS; Siddiqui, FA; Sultana, N; Zuberi, MH | 1 |
Inoue, K; Ito, S; Kusuhara, H; Sugiyama, Y; Toyoshima, J; Yokochi, M; Yuasa, H | 1 |
Harper, JN; Wright, SH | 1 |
Ahn, KS; Hong, CW; Kang, GW; Lee, DY; Lee, IH; Seo, JH | 1 |
Egawa, T; Hayashi, T; Kurogi, E; Ma, X; Ogino, Y; Oshima, R; Serizawa, Y; Tsuda, S; Yamada, M | 1 |
Jiang, HD; Lei, HM; Li, LP; Sun, SY; Tu, MJ; Zeng, S; Zhou, H | 1 |
Almond, L; Burt, HJ; Gaohua, L; Harwood, MD; Jamei, M; Neuhoff, S; Rostami-Hodjegan, A; Rowland-Yeo, K; Tucker, GT | 1 |
Duan, H; Wang, J; Yin, J | 1 |
Derdau, V; Fromm, MF; König, J; Mertsch, K; Müller, F; Sandvoss, M; Weitz, D | 1 |
Baviera, AM; Benzi, JRL; de Moraes, NV; Stevens, JH; Yamamoto, PA | 1 |
Breining, P; Bross, P; Busk, M; Fernandez-Guerra, P; Gormsen, LC; Hansen, JB; Jakobsen, S; Jensen, JB; Jessen, N; Markussen, LK; Pedersen, SB; Rasmussen, NE; Richelsen, B; Rolighed, L; Sundelin, EI | 1 |
Clark, AM; Ekins, S; Sandoval, PJ; Wright, SH; Zorn, KM | 1 |
Fromm, MF; König, J; Mertsch, K; Müller, F; Weitz, D | 1 |
Ceckova, M; Deutsch, B; Fromm, MF; Reznicek, J; Staud, F | 1 |
Caldwell, DJ; D'Aco, V; Davidson, T; Kappler, K; Robinson, PF; Simon-Hettich, B; Straub, JO; Tell, J | 1 |
Bister, B; Ishiguro, N; Lee, W; Nishiyama, K; Sugiyama, Y; Toshimoto, K | 1 |
Ebner, T; Hanke, N; Ishiguro, N; Lehr, T; Müller, F; Nock, V; Selzer, D; Stopfer, P; Türk, D; Wiebe, S | 1 |
Contreras, D; García, MA; González, PM | 1 |
Hassan, ZM; Jafarzadeh, A; Khorramdelazad, H; Masoumi, J; Nemati, M; Oladpour, O; Rezayati, MT; Taghipour, F; Taghipour, Z | 1 |
Hoshi, M; Imaoka, T; Itokawa, KI; Yamada, M; Yamamura, N | 1 |
3 review(s) available for metformin and cimetidine
Article | Year |
---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Options for pharmacological management of obesity in patients treated with atypical antipsychotics.
Topics: Amantadine; Antipsychotic Agents; Cimetidine; Cyclobutanes; Fluoxetine; Fructose; Humans; Lactones; Metformin; Nizatidine; Obesity; Orlistat; Topiramate; Weight Gain | 2002 |
1 trial(s) available for metformin and cimetidine
Article | Year |
---|---|
Pharmacokinetics of alogliptin when administered with food, metformin, or cimetidine: a two-phase, crossover study in healthy subjects.
Topics: Administration, Oral; Adult; Area Under Curve; Cimetidine; Cross-Over Studies; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Female; Food-Drug Interactions; Histamine H2 Antagonists; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Piperidines; Uracil; Young Adult | 2010 |
54 other study(ies) available for metformin and cimetidine
Article | Year |
---|---|
Exploring the role of different drug transport routes in permeability screening.
Topics: Administration, Oral; Biological Transport; Caco-2 Cells; Cell Line; Humans; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Membranes, Artificial; Models, Biological; Molecular Conformation; Monte Carlo Method; Permeability; Pharmaceutical Preparations; Pharmacokinetics | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2.
Topics: Biological Transport; Chemical Phenomena; Drug Evaluation, Preclinical; HEK293 Cells; Humans; Organic Cation Transport Proteins; Organic Cation Transporter 1; Organic Cation Transporter 2; Pharmaceutical Preparations; Reproducibility of Results; Structure-Activity Relationship; Substrate Specificity | 2013 |
Discovery of Competitive and Noncompetitive Ligands of the Organic Cation Transporter 1 (OCT1; SLC22A1).
Topics: Drug Discovery; HEK293 Cells; Humans; Ligands; Molecular Docking Simulation; Organic Cation Transporter 1; Small Molecule Libraries | 2017 |
Reduction of metformin renal tubular secretion by cimetidine in man.
Topics: Adult; Cimetidine; Female; Humans; Kidney Tubules; Kinetics; Lactates; Male; Metformin; Pyruvates | 1987 |
Dangers of new drugs. Does your facility or team have a system for incorporating new agents?
Topics: Aged; Cimetidine; Diabetes Mellitus, Type 2; Drug Information Services; Drug Interactions; Female; Humans; Medication Systems, Hospital; Metformin | 1996 |
Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin.
Topics: Animals; Biological Transport; CHO Cells; Cimetidine; Cricetinae; Intestinal Absorption; Kinetics; Liver; Metformin; Mice; Mice, Knockout; Organic Cation Transporter 1; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Tissue Distribution; Transfection | 2002 |
Case study: metformin-associated lactic acidosis: could orlistat be relevant?
Topics: Acidosis, Lactic; Anti-Obesity Agents; Anti-Ulcer Agents; Cimetidine; Drug Interactions; Female; Humans; Hypoglycemic Agents; Lactones; Metformin; Middle Aged; Orlistat | 2003 |
In vitro availability of metformin in presence of h(2) receptor antagonists.
Topics: Cimetidine; Famotidine; Gastric Juice; Histamine H2 Antagonists; Hydrogen-Ion Concentration; Intestinal Secretions; Metformin; Ranitidine | 2006 |
Comparison of the kinetic characteristics of inhibitory effects exerted by biguanides and H2-blockers on human and rat organic cation transporter-mediated transport: Insight into the development of drug candidates.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Biguanides; Cell Line; Cimetidine; Drug Design; Famotidine; Histamine H2 Antagonists; Humans; Ion Transport; Kinetics; Metformin; Organic Cation Transport Proteins; Phenformin; Ranitidine; Rats; Tetraethylammonium | 2007 |
Functional involvement of organic cation transporter1 (OCT1/Oct1) in the hepatic uptake of organic cations in humans and rats.
Topics: Animals; Carbon Radioisotopes; Cell Line; Cimetidine; Cryopreservation; DNA, Complementary; Hepatocytes; Humans; Metformin; Organic Anion Transporters, Sodium-Independent; Organic Cation Transporter 1; Pyridinium Compounds; Rats; Tetraethylammonium; Transfection; Tritium | 2007 |
OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine.
Topics: Adult; China; Cimetidine; DNA Mutational Analysis; Drug Interactions; Gene Frequency; Humans; Hypoglycemic Agents; Kidney; Male; Metabolic Clearance Rate; Metformin; Organic Cation Transport Proteins; Organic Cation Transporter 2; Polymorphism, Single Nucleotide | 2008 |
Cimetidine does not appear to influence the distribution of metformin into human milk.
Topics: Adult; Biological Transport, Active; Breast Feeding; Cimetidine; Drug Administration Schedule; Female; Humans; Hypoglycemic Agents; Infant; Infant, Newborn; Male; Metformin; Milk, Human; Organic Cation Transport Proteins; Pregnancy | 2008 |
Transcellular transport of organic cations in double-transfected MDCK cells expressing human organic cation transporters hOCT1/hMATE1 and hOCT2/hMATE1.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Biological Transport; Cell Line; Cimetidine; Dogs; Humans; Metformin; Octamer Transcription Factor-1; Organic Cation Transport Proteins; Organic Cation Transporter 2; Procainamide; Quinidine; Tetraethylammonium; Transfection | 2008 |
Effect of cationic drugs on the transporting activity of human and rat OCT/Oct 1-3 in vitro and implications for drug-drug interactions.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Benzamides; Cations; Cell Line; Cimetidine; Drug Interactions; Histamine H2 Antagonists; Humans; Isoquinolines; Lidocaine; Metformin; Organic Cation Transport Proteins; Procainamide; Quinidine; Rats | 2008 |
Involvement of human multidrug and toxin extrusion 1 in the drug interaction between cimetidine and metformin in renal epithelial cells.
Topics: Animals; Cell Line; Cell Membrane; Cell Size; Cimetidine; Cytoplasmic Vesicles; Dogs; Epithelial Cells; Histamine H2 Antagonists; Humans; Hypoglycemic Agents; Kidney; Metformin; Organic Cation Transport Proteins; Organic Cation Transporter 2; Transfection | 2009 |
The role of organic cation transporters (OCTs) in the transfer of metformin in the dually perfused human placenta.
Topics: Antipyrine; Biological Transport, Active; Cimetidine; Female; Humans; Maternal-Fetal Exchange; Metformin; Organic Cation Transport Proteins; Perfusion; Placenta; Pregnancy | 2010 |
Cimetidine-induced lactic acidosis and acute pancreatitis.
Topics: Acidosis, Lactic; Acute Disease; Cimetidine; Diabetes Mellitus, Type 2; Drug Interactions; Female; Gastroesophageal Reflux; Humans; Hypoglycemic Agents; Metformin; Middle Aged; Pancreatitis; Recurrence | 2010 |
Simultaneous determination of metformin, cimetidine, famotidine, and ranitidine in human serum and dosage formulations using HPLC with UV detection.
Topics: Adult; Chromatography, High Pressure Liquid; Cimetidine; Ethylamines; Famotidine; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Linear Models; Metformin; Methanol; Ranitidine; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tablets; Young Adult | 2010 |
Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney.
Topics: 1-Methyl-4-phenylpyridinium; 3-Iodobenzylguanidine; Animals; Binding, Competitive; Biological Transport; Cephalexin; Cimetidine; Dose-Response Relationship, Drug; Drug Interactions; HEK293 Cells; Humans; Kidney; Kinetics; Liver; Male; Metformin; Mice; Mice, Inbred Strains; Organic Cation Transport Proteins; Organic Cation Transporter 1; Organic Cation Transporter 2; Pyridines; Tetraethylammonium; Transfection | 2012 |
Multiple mechanisms of ligand interaction with the human organic cation transporter, OCT2.
Topics: 1-Methyl-4-phenylpyridinium; Androstenes; Animals; Benzhydryl Compounds; Carbazoles; Carvedilol; CHO Cells; Cimetidine; Cricetinae; Cricetulus; Humans; Inhibitory Concentration 50; Kinetics; Ligands; Metformin; Organic Cation Transport Proteins; Organic Cation Transporter 2; Piperidines; Propanolamines; Tetraethylammonium | 2013 |
Severe lactic acidosis and acute pancreatitis associated with cimetidine in a patient with type 2 diabetes mellitus taking metformin.
Topics: Acidosis, Lactic; Aged, 80 and over; Cimetidine; Diabetes Mellitus, Type 2; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Metformin; Pancreatitis; Severity of Illness Index | 2013 |
Evidence for organic cation transporter-mediated metformin transport and 5'-adenosine monophosphate-activated protein kinase activation in rat skeletal muscles.
Topics: 3-O-Methylglucose; AMP-Activated Protein Kinases; Animals; Biological Transport; Cimetidine; Energy Metabolism; Enzyme Activation; Hypoglycemic Agents; In Vitro Techniques; Male; Membrane Transport Modulators; Metformin; Muscle Fibers, Fast-Twitch; Muscle Fibers, Slow-Twitch; Organic Cation Transport Proteins; Phosphorylation; Protein Processing, Post-Translational; Random Allocation; Rats, Wistar | 2015 |
[Establishment of MDCK cell models expressing human MATE1 or co-expressing with human OCT1 or OCT2].
Topics: Animals; Biological Transport; Cimetidine; DNA, Complementary; Dogs; Drug Interactions; Humans; Madin Darby Canine Kidney Cells; Metformin; Organic Cation Transport Proteins; Transfection | 2015 |
Metformin and cimetidine: Physiologically based pharmacokinetic modelling to investigate transporter mediated drug-drug interactions.
Topics: Anti-Ulcer Agents; Cimetidine; Computer Simulation; Drug Carriers; Drug Interactions; Electrochemistry; Hypoglycemic Agents; Kidney; Liver; Metformin; Models, Biological; Organic Cation Transport Proteins | 2016 |
Impact of Substrate-Dependent Inhibition on Renal Organic Cation Transporters hOCT2 and hMATE1/2-K-Mediated Drug Transport and Intracellular Accumulation.
Topics: Animals; Atenolol; Biological Transport; Cimetidine; Dogs; Drug Interactions; HEK293 Cells; Humans; Intracellular Space; Kidney; Madin Darby Canine Kidney Cells; Metformin; Organic Cation Transport Proteins; Organic Cation Transporter 2; Pharmaceutical Preparations | 2016 |
Contribution of MATE1 to Renal Secretion of the NMDA Receptor Antagonist Memantine.
Topics: Animals; Biological Transport; Cell Line; Cimetidine; Dogs; HEK293 Cells; Humans; Kidney; Madin Darby Canine Kidney Cells; Memantine; Metformin; Organic Cation Transport Proteins; Organic Cation Transporter 2; Receptors, N-Methyl-D-Aspartate | 2017 |
The role of organic cation transporter 2 inhibitor cimetidine, experimental diabetes mellitus and metformin on gabapentin pharmacokinetics in rats.
Topics: Amines; Animals; Cimetidine; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Experimental; Gabapentin; gamma-Aminobutyric Acid; Male; Metformin; Organic Cation Transporter 2; Rats; Rats, Wistar | 2018 |
Metformin targets brown adipose tissue in vivo and reduces oxygen consumption in vitro.
Topics: Adipose Tissue, Brown; Animals; Cimetidine; Dose-Response Relationship, Drug; Humans; Hypoglycemic Agents; Metformin; Mice; Octamer Transcription Factor-3; Organic Cation Transport Proteins; Oxygen Consumption; Positron Emission Tomography Computed Tomography; Transcriptome | 2018 |
Assessment of Substrate-Dependent Ligand Interactions at the Organic Cation Transporter OCT2 Using Six Model Substrates.
Topics: Animals; CHO Cells; Cimetidine; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Histamine H2 Antagonists; Hypoglycemic Agents; Ligands; Metformin; Models, Chemical; Organic Cation Transporter 2; Protein Binding; Substrate Specificity | 2018 |
Importance of OCT2 and MATE1 for the Cimetidine-Metformin Interaction: Insights from Investigations of Polarized Transport in Single- And Double-Transfected MDCK Cells with a Focus on Perpetrator Disposition.
Topics: Animals; Cimetidine; Dogs; Drug Interactions; HEK293 Cells; Humans; Kidney Tubules; Madin Darby Canine Kidney Cells; Metformin; Organic Cation Transport Proteins; Organic Cation Transporter 2; Renal Elimination | 2018 |
Efavirenz reduces renal excretion of lamivudine in rats by inhibiting organic cation transporters (OCT, Oct) and multidrug and toxin extrusion proteins (MATE, Mate).
Topics: Alkynes; Animals; Area Under Curve; Benzoxazines; Cimetidine; Cyclopropanes; Dogs; Half-Life; HEK293 Cells; Humans; Kidney; Lamivudine; Madin Darby Canine Kidney Cells; Male; Metformin; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organic Cation Transport Proteins; Rats; Rats, Wistar; Renal Elimination; Reverse Transcriptase Inhibitors; ROC Curve | 2018 |
Environmental risk assessment of metformin and its transformation product guanylurea. I. Environmental fate.
Topics: Animals; Biodegradation, Environmental; Cimetidine; Humans; Hypoglycemic Agents; Metformin; Risk Assessment; Water Pollutants, Chemical | 2019 |
Physiologically-Based Pharmacokinetic Modeling Analysis for Quantitative Prediction of Renal Transporter-Mediated Interactions Between Metformin and Cimetidine.
Topics: Algorithms; Biological Transport; Cimetidine; Drug Interactions; Humans; Kidney; Metabolic Clearance Rate; Metformin; Models, Biological | 2019 |
A Comprehensive Whole-Body Physiologically Based Pharmacokinetic Drug-Drug-Gene Interaction Model of Metformin and Cimetidine in Healthy Adults and Renally Impaired Individuals.
Topics: Adult; Cimetidine; Drug Interactions; Humans; Hypoglycemic Agents; Metformin; Pharmacogenetics; Renal Insufficiency, Chronic | 2020 |
Metformin Transport in Native MDCK-Wt and MDCK-II Monolayers Unveils Functional Inter-Strains Differences Influencing Drug Permeability.
Topics: Animals; Biofilms; Biological Transport; Cell Adhesion; Cells, Cultured; Cimetidine; Diffusion; Dogs; Humans; Hydrogen-Ion Concentration; Lopinavir; Madin Darby Canine Kidney Cells; Metformin; Pyrimethamine; Quinidine | 2020 |
Modulatory Effects of Metformin Alone and in Combination with Cimetidine and Ibuprofen on T Cell-related Parameters in a Breast Cancer Model.
Topics: Animals; Biomarkers; Breast Neoplasms; Cell Line, Tumor; Cimetidine; Disease Models, Animal; Female; Humans; Ibuprofen; Immunomodulation; Metformin; Mice; T-Lymphocyte Subsets; T-Lymphocytes | 2021 |
Renal tubular transporter-mediated interactions between mirogabalin and cimetidine in rats.
Topics: Animals; Cimetidine; Humans; Kidney; Metformin; Organic Cation Transport Proteins; Organic Cation Transporter 2; Rats | 2023 |